Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 4
- 主要终点
- Completion rate
研究概览
简要总结
This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based materials and resources. STAND-T may help improve health, address symptoms, and promote equity in men with prostate cancer.
详细描述
PRIMARY OBJECTIVE:
I. To assess study feasibility of the STAND-T program at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) and Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) genitourinary (GU) medical, surgical, and radiation oncology practices.
SECONDARY OBJECTIVE:
I. To measure preliminary estimates of acceptability and usage of a digital platform, STAND-T.
EXPLORATORY OBJECTIVE:
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Age >18 years
- •Ability to understand study procedures and to comply with them for the entire length of the study
- •Ability of individual or legal guardian/representative to understand an informed consent document and the willingness to sign it
- •Adenocarcinoma of the prostate
- •Current or planned anti-androgen therapy (ADT) (oral or injection) with gonadotropin-releasing hormone (GnRH) antagonist or luteinizing hormone releasing hormone (LHRH) agonist
- •Life expectancy duration of 6 months or longer from date of study consent
- •Prior and concurrent radiation is allowed
- •Treatment with concurrent androgen signaling inhibitors is allowed
- •< 75 minutes/week of vigorous aerobic exercise based on Godin survey or < 2 days per week of vigorous activity
排除标准
- •Contraindication to any study-related procedure or assessment
- •Planned surgery/chemotherapy/immunotherapy/parp inhibitor treatment during the study period
- •Prior and concurrent investigational therapies
- •Unable to read/speak English
- •Unable to access the Internet
- •Has seen an exercise counselor in the past 6 months for prostate or cardiovascular health
- •Has seen a dietary counselor in the past 6 months for prostate or cardiovascular health
结局指标
主要结局
Completion rate
时间窗: Up to 3 months
The point estimation and 95% confidence interval (CI) of the percentage of participants who complete the 3-month study will be obtained overall and by race/ethnicity and geography.
次要结局
- Participants reported satisfaction level(Up to 3 months)
- Change in the proportion of men who were Extremely Satisfied/Satisfied(Up to 3 months)